{'fraction_non_alphanumeric': 0.03988183161004431, 'fraction_numerical': 0.01772525849335303, 'mean_word_length': 5.58252427184466, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
RESILIA Aortic Tissue Valve ITAlian Registry (RES-ITA): Early and Mid-term Results

Methods: RES-ITA Registry is the Italian multicenter registry created in 2017, enrolling patients who underwent isolated or combined AVR with RESILIA tissue valve. Isolated AVR (53%) was performed through an upper J mini-sternotomy or a right anterior mini-thoracotomy, while combined procedures (47%) were performed in full sternotomy and included associated CABG, ascending aorta surgery, mitral valve repair or replacement, aortic annulus enlargement. For all patients, clinical and echocardiographic assessment were evaluated at discharge, 30 days, 6 months, one and 2 years after surgery.